501 Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma who were treated beyond progression in a randomized phase 2 dose-ranging trial. (September 2015) - George, S.; Motzer, R.J.; Hammers, H.; Redman, B.; Kuzel, T.; Tykodi, S.S.; Plimack, E.; Jiang, J.; Waxman, I.; Rini, B.I.